De novo renal cell carcinoma of native and graft kidneys in renal transplant recipients

BJU International

Volumn 108, Issue 2, 2011, Pages 229-234

  Tsaur, Igor ^a,c   Obermüller, Nicholas ^a   Jonas, Dietger ^a   Blaheta, Roman ^a   Juengel, Eva ^a   Scheuermann, Ernst Heinrich ^a,b   Kachel, Heinz Georg ^b   Karalis, Athanasios ^a   Probst, Michael ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b KFH Kidney Center   (Germany)

^c NONE   (Germany)

Author keywords

dialysis; graft tumour; immunosuppression; papillary; renal cell carcinoma; renal transplantation

Indexed keywords

ALPHA INTERFERON; CAPECITABINE; CREATININE; FLUOROURACIL; INTERLEUKIN 2; RAPAMYCIN; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER GRADING; CANCER GRAFT; CANCER MORTALITY; CANCER REGRESSION; CANCER RISK; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL EVALUATION; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY CARCINOMA; KIDNEY GRAFT; KIDNEY METASTASIS; KIDNEY TUMOR; LUNG METASTASIS; MALE; NEPHRECTOMY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEINURIA; RENAL GRAFT DYSFUNCTION; RETROSPECTIVE STUDY; SURVIVAL RATE; SYSTEMIC THERAPY; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEPHRECTOMY; PROGNOSIS;

EID: 79959971005     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09856.x     Document Type: Article

References (37)

1. Morris PJ,. Transplantation-a miracle of the 20th century. N Engl J Med 2004; 351: 2678-80
2. Penn I,. Malignancy in renal transplant recipients. Saudi J Kidney Dis Transplant 1996; 7: 1-5
3. Penn I,. Post-transplant malignancy: the role of immunosupression. Drug Saf 2000; 23: 101-13
4. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C,. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905-13 (Pubitemid 38745589)
5. Doublet J, Peraldi M, Gattegno B, Sraer JD,. Renal cell carcinoma of native kidneys: prospective study of 129 renal transplant patients. J Urol 1997; 158: 42-4 (Pubitemid 27251590)
6. Penn I,. Post-transplantation malignancies. Transplant Proc 1999; 31: 1260-2
7. American Joint Committee on Cancer. Kidney. AJCC Cancer Staging Manual 2002; 6: 325
8. Fuhrman SA, Lasky LC, Limas C,. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6: 655-63 (Pubitemid 13234762)
9. Eble JN, Sauter G, Epstein JI, Sesterhenn IA,. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. World Health Organization Classification of Tumors. Lyons: IARC Press, 2004: 7
10. Registries. European Network of Cancer. Eurocim version 4.0. European incidence database. V2.3: 730 entity dictionary, 2001
11. Sheil A, Flavel S, Disney A, Mathew TH,. Cancer development in patients progressing to dialysis and renal transplant. Transplant Proc 1985; 17: 1685-8 (Pubitemid 15108276)
12. Diller R, Gruber A, Wolters H, Spiegel HU,. Therapy and prognosis of tumors of the genitourinary tract after kidney transplantation. Transplant Proc 2005; 37: 2089-92 (Pubitemid 40956381)
13. Ianhez LE, Lucon M, Nahas WC, et al. Renal cell carcinoma in renal transplant patients. Urology 2007; 69: 462-4 (Pubitemid 46428387)
14. Moudouni S, Lakmichi A, Tligui M, et al,. Renal cell carcinoma of native kidney in renal transplant recipients. BJU Int 2006; 98: 298-302
15. Filocamo M, Zanazzi M, Li Marzi V, et al,. Renal cell carcinoma of native kidney after renal transplantation: clinical relevance of early detection. Transplant Proc 2009; 41: 4197-201
16. Barrett W, First M, Aron B, Penn I,. Clinical course of malignancies in renal transplant recipients. Cancer 1993; 72: 2186-9 (Pubitemid 23280145)
17. Kojima Y, Takahara S, Miyake O, Nonomura N, Morimoto A, Mori H,. Renal cell carcinoma in dialysis patients. A single center experience. Int J Urol 2006; 13: 1045-8 (Pubitemid 44125674)
18. Denton M, Magee C, Ovuworie C, et al,. Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int 2002; 61: 2201-9 (Pubitemid 34539338)
19. Penn I,. Primary kidney tumors before and after renal transplantation. Transplantation 1995; 59: 480-5
20. Sandock S, Seftel A, Resnick M,. A new protocol for the follow up of renal cell carcinoma based on pathological stage. J Urol 1995; 154: 28-31
21. Truong LD, Krishnan B, Cao JT, Barrios R, Suki WN,. Renal neoplasm in acquired cystic kidney. Am J Kidney Dis 1995; 26: 1-12
22. Schwarz A, Vatandaslar S, Merkel S, Haller H,. Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol 2007; 2: 750-6
23. Ishikawa I,. Renal cell carcinoma in chronic hemodialysis patients-a 1990 questionnaire study in Japan. Kidney Int Suppl 1993; 41: 167-9
24. Chapman AB, Rahbari-Oskouri FF,. Acquired cystic disease of the kidney in adults. Up To Date version 15.1, 2007. Available at: http://www.uptodate.com. Accessed 15 March 2010
25. Oya M, Mikami S, Muzino R, Marumo K, Mukai M, Murai M,. C-jun activation in acquired cystic kidney disease and renal cell carcinoma. J Urol 2005; 174: 726-30 (Pubitemid 40981644)
26. Neuzillet Y, Lay F, Luccioni A, et al,. De novo renal cell carcinoma of native kidney in renal transplant recipients. Cancer 2005; 103: 251-7 (Pubitemid 40129283)
27. Klatte T, Seitz C, Waldert M, et al,. Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients. BJU Int 2010; 105: 1260-5
28. Sasagawa I, Terazawa Y, Ishizagi M, et al,. Comparison of ultrasonography, CT and angiography in dialysis patients with renal cell carcinoma. Urol Int 1992; 49: 206-10
29. Wiesel M, Carl S, Drehmer I, Hofmann WJ, Zeier M, Staehler G,. The clinical significance of renal cell carcinoma in dialysis dependent patients in comparison with kidney transplant recipients. Urologe A 1997; 36: 126-9
30. Blom JH, van Poppel H, Marechal JM, et al,. Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881. Eur Urol 2009; 55 (Suppl. 1): 28-34
31. Ljunberg B, Hanbury DC, Kuczyk MA, et al,. Guidelines on renal cell carcinoma. European Association of Urology (EAU) Update 2009. Available at: http://www.uroweb.org/fileadmin/tx-eauguidelines/2009/Full/RCC.pdf. Accessed 22 February 2010
32. Cussenot O, Fournier G,. Genetics and urology. Prog Urol 2000; 10: 681-1097
33. Hoda MR, Hamza A, Wagner S, Greco F, Fornara P,. Recurrence of renal cell carcinoma in a renal allograft after partial transplant nephrectomy: a case report. Urol Int 2009; 83: 239-41
34. Matevossian E, Novotny A, Vogelsang B, et al,. Noninvasive therapy of incidental de novo renal cell carcinoma in a kidney allograft 12 years after transplantation: report of a case and review of literature. Transplant Proc 2008; 40: 915-7 (Pubitemid 351794297)
35. Ljungberg B, Landberg G, Alamdari FI,. Factors of importance for prediction of survival in patients with metastatic renal cell carcinoma, treated with or without nephrectomy. Scand J Urol Nephrol 2000; 34: 246-51 (Pubitemid 32061331)
36. Luan FL, Hojo M, Maluccio M, Yamaji K, Suthanthiran M,. Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy. Transplantation 2002; 73: 1565-72 (Pubitemid 34568667)
37. Kälble T, Alcaraz A, Budde K, et al,. Guidelines on renal transplantation. European Association of Urology (EAU) 2009. Available at: http://www.uroweb.org/fileadmin/tx-eauguidelines/2009/Full/Renal-Transplant.pdf. Accessed 27 February 2010